32 Delbert Robinson On Barriers To Use Of Long Acting Injectable Antipsychotics

Delbert G. Robinson, M.D., joins Dr. Dixon and Dr. Berezin to discuss barriers to the use of long-acting injectable (LAI) antipsychotic medication ( ps.psychiatryonline.org/doi/10.1176/appi.ps.201900236).

Dr. Robinson's path to this particular area of research [1:43]
How have people traditionally viewed LAIs? [3:32]
A different approach to LAIs [4:13]
The trend to use qualitative methods to understand perspectives of different stakeholders [7:28]
Scope of the study [8:13]
What the barriers are to more uptake of the use of LAIs [14:18]
Barriers stemming from the individual level (interactions between a clinician and a patient) and the systems level (clinics not having appropriate infrastructure) [19:48]
What is the next step in this line of research? [22:20]

Subscribe to the podcast: ps.psychiatryonline.org/podcast

Check out Editor's Choice, a new set of curated collections from the rich resource of articles published in the journal: ps.psychiatryonline.org/editorschoice

Sign up to receive notification of new Editor's Choice collections: appi.org/etocs

Browse other articles on our web site: ps.psychiatryonline.org/

Be sure to let your colleagues know about the podcast, and please rate and review it wherever you listen to it.

Listen to other podcasts produced by the American Psychiatric Association: psychiatry.org/psychiatrists/education/podcasts

Follow the journal on Twitter: twitter.com/APAPubJournals

E-mail us: psjournal@psych.org

Author

Ariyani

Como educador, estou profundamente engajado no desenvolvimento dos estudantes em ambiente escolar, adotando métodos pedagógicos que valorizam conexões genuínas e são movidos por inovação e fervor. É minha vocação guiar os alunos na jornada de se tornarem uma geração notável, empregando estratégias de ensino amplamente aclamadas por prestigiadas instituições acadêmicas ao redor do globo - events.zulekhahospitals.com